Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_assertion description "[There is evidence that UG, which is a potent inhibitor of the activity of phospholipases A2, has anti-proliferative effects and we have previously demonstrated that enforced UG expression reverts the transformed phenotype in the endometrial cancer cell line HEC-1A.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_assertion evidence source_evidence_literature NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_assertion SIO_000772 14719079 NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_assertion wasDerivedFrom befree-20150227 NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_assertion wasGeneratedBy ECO_0000203 NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP843038.RA7zi0Ml4O8_OWqxkvcuF6ZfhP4t8RYh7y4xgqCDfunPU130_provenance.